Curaleaf Holdings Inc. (CURA.TO) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Curaleaf Holdings Inc. ranks 12 of 12 in its cohort on the Closelook composite (31/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
CURA.TO Curaleaf Holdings Inc. 31 65 22 26
ROVI.MC Laboratorios Farmaceuticos ROVI 60 20 76 51 info 32.3%
LNTH Lantheus Holdings Inc 60 69 75 58 info 10.1%
KNSA Kiniksa Pharmaceuticals Ltd 56 92 58 19 ok 6.9%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 54 89 57 42 ok 2.9%
BHC.TO Bausch Health Companies Inc 54 50 70 83 info 28.5%
ALKS Alkermes Plc 53 66 52 22 info 22.1%
APTX.TO Apotex Health Corp 48 59 56 48
BION.SW BB Biotech AG 74 74 96 81 info 8.2%
DXCM DexCom Inc 66 86 80 35 bull 5%
ARGX.BR Argen-X 65 79 75 28 ok 5.8%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Curaleaf Holdings Inc.'s peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Bausch Health Companies Inc (BHC.TO), Alkermes Plc (ALKS), Apotex Health Corp (APTX.TO), BB Biotech AG (BION.SW) and others.

How does CURA.TO score against its peers?

Curaleaf Holdings Inc.'s composite reads 31/100, ranking 12 of 12 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.